Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Professor Sarah Gilbert, creator of AstraZeneca&nbsp;vaccine said that Covid-19 is unlikely mutate into a deadlier variant.&nbsp;
It will eventually just be a 'common cold', just like four other coronaviruses&nbsp;that circulate widely in the air.&nbsp;
Speaking at Royal Medical Society seminar, she also said that work on a tweaked vaccine against Beta variant only gave 'slightly better' immune response. However, data is still being collected on it.&nbsp;
Professor Gilbert's comments come just as Professor Chris Witty, Chief Medical Officer of England warned that non&nbsp;vaccinated children are at a risk of contracting Covid-19 at least once.&nbsp;

'Covid is going to just become a cold': creator of AstraZeneca vaccine, Sarah Gilbert

Professor Sarah Gilbert, the creator of life saving AstraZeneca&nbsp;vaccine has said that Covid-19 will eventually just be a 'common cold'. Watch this report

Professor Sarah Gilbert, the creator of AstraZeneca&nbsp;vaccine has said that Covid-19 is unlikely mutate into a deadlier variant.&nbsp;
She said it will eventually just be a 'common cold', just like four other coronaviruses&nbsp;that circulate widely in the air.&nbsp;
Speaking at Royal Medical Society seminar, she also said that work on a tweaked vaccine against Beta variant only gave 'slightly better' immune response. However, data is still being collected on it.&nbsp;
Gilbert's comments come just as Professor Chris Witty, the Chief Medical Officer of England warned that non&nbsp;vaccinated children are at a risk of contracting Covid-19 at least once.&nbsp;

At a Royal Society of Medicine seminar Professor Gilbert said that Covid-19 will eventually just be a common cold similar to other coronaviruses. The CMO&nbsp;of Eng comments all unvaccinated&nbsp;children to get coronavirus&nbsp;once.&nbsp;

Professor Sarah Gilbert, the creator of AstraZeneca&nbsp;vaccine has said that Covid-19 is unlikely to mutate into a deadlier variant.&nbsp;
It will eventually just be a 'common cold', just like four other coronaviruses&nbsp;that circulate widely in the air, she added.&nbsp;
Speaking at Royal Medical Society seminar, she also said that work on a tweaked vaccine against Beta variant only gave 'slightly better' immune response. However, data is still being collected on it.&nbsp;
Professor Gilbert's comments come just as Professor Chris Witty, Chief Medical Officer of England warned that non&nbsp;vaccinated children are at a risk of contracting Covid-19 at least once.&nbsp;

Boosting hope, study finds Oxford virus vaccine builds strong immunity

Bristol University study has found that the Oxford&nbsp;Covid-19 vaccine builds strong immunity to the virus.&nbsp;

Oxford coronavirus vaccine builds strong immunity, study finds

Study: Oxford vaccine builds strong immunity to Covid-19 New study on Oxford vaccine&nbsp;boosts global vaccination hope&nbsp; Vaccine front runner&nbsp;has entered Phase III clinical trials Study confirms vaccine successful in creating spike protein&nbsp; Vaccine induces strong immune response, study suggests

In a boost to global coronavirus vaccination hopes, a study has found that the Covid-19 vaccine spearheaded by Oxford University builds strong immunity to the virus. As the front-runner in the global race for a vaccine entered final Phase III clinical trials, researchers at Bristol University carried out tests to check whether it was behaving as intended. The Bristol team found that the vaccine was successfully able to instruct human cells to copy the genetic instructions to create the spike protein. The study confirmed that large amounts of the coronavirus spike protein are produced with great accuracy, and this goes a long way to explaining the success of the vaccine in inducing a strong immune response. Sarah Gilbert, who leads the Oxford University vaccine trial, praised the study for helping to explain the vaccine&rsquo;s effectiveness.

sarah gilbert

Categories